NMTC Stock Catalyst: NeuroOne Medical Technologies Corp Completed Three Large-Animal StereoCED Procedures

Aug 27, 2026 · 9:01am ET

The procedures included combined drug delivery and brain recording.

Max move

+65.4%

High of day $3.49

Sparker timei

9:01am ET

NMTC · Aug 27, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

NeuroOne Medical Technologies Corp (NMTC) has completed three large-animal StereoCED procedures. These procedures involved combined drug delivery and brain recording, showcasing the company's advancements in medical device technology.

The completion of these procedures marks a significant step in NeuroOne's research and development efforts. The company continues to innovate in the medical device sector, focusing on enhancing patient outcomes through advanced technologies.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time NMTC sparks.

Download Sniper App →

Catch the next NMTC-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →